Beta Blocker Therapy in Moderate to Severe COPD

Summary

Beta Blocker Therapy in Moderate to Severe COPD is a clinical trial^[1].

Key Facts

• Beta Blocker Therapy in Moderate to Severe COPD is in the country of United Kingdom^[2].
• Beta Blocker Therapy in Moderate to Severe COPD's instance of is recorded as clinical trial^[3].
• Beta Blocker Therapy in Moderate to Severe COPD's start time is recorded as +2012-08-31T00:00:00Z^[4].
• Beta Blocker Therapy in Moderate to Severe COPD's end time is recorded as +2016-07-31T00:00:00Z^[5].
• Beta Blocker Therapy in Moderate to Severe COPD's sponsor is recorded as University of Dundee^[6].
• Beta Blocker Therapy in Moderate to Severe COPD's main subject is recorded as chronic obstructive pulmonary disease^[7].
• Beta Blocker Therapy in Moderate to Severe COPD's main subject is recorded as Impulse oscillometry in COPD: Identification of measurements related to airway obstruction, airway conductance and lung volumes^[8].
• Beta Blocker Therapy in Moderate to Severe COPD's number of participants is recorded as {'unit': '1', 'amount': '+18'}^[9].
• Beta Blocker Therapy in Moderate to Severe COPD's title is recorded as Evaluation of Effects of Chronic Dose Exposure to Cardioselective and Non-cardioselective Beta Blockers on Measures of Cardiopulmonary Function in Moderate to Severe COPD.^[10].
• Beta Blocker Therapy in Moderate to Severe COPD's short name is recorded as ANDA2^[11].
• Beta Blocker Therapy in Moderate to Severe COPD's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[12].
• Beta Blocker Therapy in Moderate to Severe COPD's ClinicalTrials.gov ID is recorded as NCT01656005^[13].
• Beta Blocker Therapy in Moderate to Severe COPD's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[14].
• Beta Blocker Therapy in Moderate to Severe COPD's research intervention is recorded as formoterol fumarate^[15].
• Beta Blocker Therapy in Moderate to Severe COPD's research intervention is recorded as tiotropium bromide^[16].
• Beta Blocker Therapy in Moderate to Severe COPD's research intervention is recorded as carvedilol^[17].
• Beta Blocker Therapy in Moderate to Severe COPD's research intervention is recorded as bisoprolol / hydrochlorothiazide^[18].
• Beta Blocker Therapy in Moderate to Severe COPD's research intervention is recorded as beclometasone^[19].
• Beta Blocker Therapy in Moderate to Severe COPD's clinical trial phase is recorded as phase IV clinical trial^[20].
• Beta Blocker Therapy in Moderate to Severe COPD's study type is recorded as interventional study^[21].